Navigation Links
West Announces Third Quarter 2009 Results
Date:11/3/2009

astef Investissements SA in July 2009, which contributed $4.0 million in sales of proprietary safety needle products. 2009 results do not include revenues from the Tech Group's former Mexico facility, which was sold in the fourth quarter of 2008. That facility generated $2.7 million of primarily industrial contract manufacturing revenue in the third quarter of 2008 that was not transferred to other West locations following the sale of the facility.

Gross profit was $8.3 million in the quarter, $1.5 million lower than the $9.8 million reported in third quarter of 2008, and gross profit margin was 13.2% compared to 14.4% in the prior year period. Acquisitions and dispositions had no material effect on gross profit. The decline was primarily the result of the negative marginal effect of reduced sales revenue and production throughput, which outpaced the net positive effects of lower raw material and energy costs. SG&A costs increased $0.7 million on higher information technology and compensation costs. Operating profit for the third quarter of 2009 was $2.6 million, compared to $5.1 million in the prior year quarter, reflecting the inefficiencies associated with the lower revenue and utilization.

Corporate and Other

U.S. pension expense was $4.3 million in the current quarter, a $2.8 million increase over the third quarter of 2008, primarily as a result of substantial investment losses incurred by the U.S. pension plan assets during 2008. Similar effects are being reported in each 2009 quarter.

Stock-based compensation expense decreased by $0.6 million compared to the prior year quarter, due primarily to a change in the estimated cost of the Company's long-term incentive plan. Other corporate general and administrative costs were substantially unchanged compared to the prior year quarter as increases in depreciation and short-term incentive plan costs were offset by reduced utilization of external service pro
'/>"/>

SOURCE West Pharmaceutical Services, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... Aug. 5, 2015 Karuna Pharmaceuticals, Inc. ... developing a novel product candidate for the treatment ... a Translation Fund Award from the Wellcome Trust ... up to $3.84 million. The funding, along with ... Karuna,s lead program KarXT, a potentially innovative therapy ...
(Date:8/4/2015)... , England , Aug. ... and UK biotechnology company Synairgen plc (LSE: SNG) today announced ... selective inhibitor to the lysyl oxidase type 2 enzyme (LOXL2) ... IPF affects in the region of 100,000 ... global revenues in excess of $1.1 billion by 2017. The LOXL2 ...
(Date:8/4/2015)... -- On August 3, 2015, a press conference on anti-virus ... donation ceremony of a million masks by Wuhan Longfeixiang Technology ... . Wuhan Longfeixiang Technology ... Hubei Longfeixiang Industrial Group, which has successfully developed the ... anti-pollution mask, filling the global gap for masks of ...
Breaking Medicine Technology:Karuna Receives Wellcome Trust Award to Advance Innovative Clinical Stage Product Candidate for the Treatment of Schizophrenia 2Karuna Receives Wellcome Trust Award to Advance Innovative Clinical Stage Product Candidate for the Treatment of Schizophrenia 3Karuna Receives Wellcome Trust Award to Advance Innovative Clinical Stage Product Candidate for the Treatment of Schizophrenia 4Pharmaxis and Synairgen Announce Research Collaboration to Develop LOXL2 Inhibitor For Pulmonary Fibrosis 2Pharmaxis and Synairgen Announce Research Collaboration to Develop LOXL2 Inhibitor For Pulmonary Fibrosis 3
(Date:8/5/2015)... ... August 05, 2015 , ... National testosterone ... multidistrict litigation known as Testosterone Replacement Therapy Products Liability Litigation, MDL 2545, which ... The Motion to Dismiss was filed by the defendants, who include AbbVie and ...
(Date:8/5/2015)... Phoenix, AZ (PRWEB) , ... August 05, 2015 , ... ... , Stelari is reinventing yoga wear with their new line, The Earth’s Song. Combining ... the street and into your workout. Inspired by the Australian Outback, this collection is ...
(Date:8/5/2015)... ... August 05, 2015 , ... " Wildflower Seed & Tool ... takes a look small, medium, and large businesses making an impact in their industry. ... and shared with viewers how their gardening tools are specifically designed for women. , ...
(Date:8/5/2015)... ... , ... A leader in Primary Care Continuing Medical Education (CME), Continuing ... Barnwell as its new Director of Program Management. , Su has over 16 years ... for Primary Care Network (PCN) as the Director, Program Implementation as well as Supervisor ...
(Date:8/5/2015)... ... August 05, 2015 , ... Available in select spas ... formulated with a quartet of beauty-enhancing marine and plant oils. A perfect complement to ... oil which stands out for its lovely scent and soothing properties. Formulated as a ...
Breaking Medicine News(10 mins):Health News:Testosterone Lawsuit News: Defendants Push Back Against RICO Claim 2Health News:Testosterone Lawsuit News: Defendants Push Back Against RICO Claim 3Health News:Testosterone Lawsuit News: Defendants Push Back Against RICO Claim 4Health News:Stelari: Bohemian Chic Activewear Line 2Health News:Stelari: Bohemian Chic Activewear Line 3Health News:Wildflower Seed & Tool Company Design Gardening Tools Specifically for Women 2Health News:Leading Continuing Medical Education (CME) Provider, Continuing Education Company (CEC), hires expert Su Barnwell as Director of Program Management 2Health News:Leading Continuing Medical Education (CME) Provider, Continuing Education Company (CEC), hires expert Su Barnwell as Director of Program Management 3Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 2Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 3Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 4
... medical researchers in the United States has discovered what may ... cancer.// ,The scientists from the University of ... halting the activity of a single enzyme called aldose reductase. ... of biochemical signals that promotes inflammation and colon cancer cell ...
... of interest for post menopausal women with breast cancer ... Herceptin (trastuzumab) from Roche// and Arimidex (anastrozole) from AstraZeneca ... time by 4.8 months. ,A Phase III clinical ... the progression by just 2.4 months after which the ...
... people affected by chikungunya, a viral fever caused by mosquitoes//, ... the state government on the nature of the disease. ... not chikungunya. The government is doing its best to contain ... have asked people from other systems of medicines like Ayurveda ...
... an undiagnosed disorder and fighting to stay in Canada, has ... state after three years.// ,"I just hugged them... and ... parents landed at Vancouver airport last week. ,Dhaval ... Gujarat advised him to move after looking at his condition ...
... It was just weeks following the 9/11 attacks in ... offices of the news media and two US senators//. The ... five people and infected 17 others. , ,In a ... University of Georgia, teaming up with scientists at the federal ...
... and at times even forbid birthday cupcakes due to ... bring carrots," said Laura Ott, assistant to the superintendent.,A ... a sticker and a pencil instead of sweets from ... Unified School District, in Orange County, Calif., has restricted ...
Cached Medicine News:Health News:Indian with Rare Disorder Reunited with Family 2Health News:Cell-Wall Carbohydrate in Anthrax Bacterium Holds Promise for New Vaccines 2
... The MasterControl architecture is the ... application and provides all the essential ... or quality management system to boost ... drive compliance with regulatory and quality ...
... 40 FL laboratory microscope from Carl ... stability of research-class instruments with a ... ideal for routine clinical applications in ... addition, it has numerous applications in ...
... Systems from Helmer use both controlled temperature and ... the safety of your plasma. The DH4 (4 ... baskets with independent controls that will accommodate a ... also convenient to operate, allowing you to load, ...
... Our thawing systems are automated, easy ... sealed from the outside environment by flexible ... airborne bacterial or viral contamination of the ... capacities, the systems can also accommodate bags ...
Medicine Products: